Cell MedX Corp (CMXC)

Healthcare | Medical Devices
Income Statement (Quarterly) 2025-08-31 2025-02-28 2024-11-30 2024-08-31
Revenue 0 0 0 0
Cost of Revenue 0 0 0 0
Gross Profit 0 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 139,484 32,847 57,424 51,345
Operating Expenses 252,354 131,086 79,924 73,845
Operating Income 0 0 0 -73,845
Interest Expense 0 0 8,810 8,852
Income Before Tax -265,602 -140,537 -139,508 -66,919
Income Tax Expense 0 0 0 0
Net Income -265,602 -140,537 -139,508 -66,919
Per Share
EPS -0.01 -0.01 -0.01 0.00
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Revenue 0 0 2,762 6,065 6,762
Cost of Revenue 0 0 2,279 2,032 3,240
Gross Profit 0 0 483 4,033 3,522
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 213,452 290,891 358,921 523,872 454,094
Operating Expenses 522,106 313,430 448,141 675,726 686,109
Operating Income 0 -313,430 -445,379 -671,693 -682,587
Interest Expense 0 0 47,384 25,686 -32,020
Income Before Tax -566,293 -142,486 -495,042 -697,379 -910,836
Income Tax Expense 0 0 -170,174 25,686 0
Net Income -566,293 -142,486 -495,042 -723,065 -910,836
Per Share
EPS -0.03 0.00 -0.01 -0.01 -0.02
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Assets
Cash and Cash Equivalents 14,581 43,415 98,295 24,380
Short Term Investments 0 0 0 0
Net Receivables 0 1,807 3,225 8,775
Inventory 0 0 0 -8,775
Total Current Assets 14,581 46,122 103,270 41,344
Property Plant Equipment 0 0 0 0
Goodwill and Intangibles 0 0 0 0
Total Assets 21,222 46,122 103,270 41,344
Liabilities
Account Payables 322,144 288,891 408,264 442,439
Short Term Debt 0 313,490 1,001,024 616,781
Total Current Liabilities 322,144 872,577 2,488,750 2,050,375
Long Term Debt 0 0 0 0
Total Liabilities 1,267,508 872,577 2,488,750 2,050,375
Shareholders Equity
Retained Earnings -10,861,556 -10,295,263 -10,152,777 -9,657,735
Total Shareholders Equity -1,246,286 -826,455 -2,385,480 -2,009,031
Balance Sheet (Annual) 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Assets
Cash and Cash Equivalents 14,581 43,415 98,295 24,380 20,753
Short Term Investments 0 0 0 0 0
Net Receivables 0 1,807 3,225 8,775 12,423
Inventory 0 0 0 -8,775 0
Total Current Assets 14,581 46,122 103,270 41,344 51,047
Property Plant Equipment 0 0 0 0 1,195
Goodwill and Intangibles 0 0 0 0 0
Total Assets 21,222 46,122 103,270 41,344 52,242
Liabilities
Account Payables 322,144 288,891 408,264 442,439 431,593
Short Term Debt 0 313,490 1,001,024 616,781 343,668
Total Current Liabilities 322,144 872,577 2,488,750 2,050,375 1,628,300
Long Term Debt 0 0 0 0 0
Total Liabilities 1,267,508 872,577 2,488,750 2,050,375 1,628,300
Shareholders Equity
Retained Earnings -10,861,556 -10,295,263 -10,152,777 -9,657,735 -8,960,356
Total Shareholders Equity -1,246,286 -826,455 -2,385,480 -2,009,031 -1,576,058
Cash Flow Statement (Quarterly) 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Operating Activities
Net Income -566,293 -142,486 -495,042 -697,379
Depreciation & Amortization 0 0 0 1,145
Stock Based Compensation 0 0 0 0
Change in Working Capital 0 116,074 104,308 137,976
Operating Cash Flow -141,600 -145,898 -272,209 -450,591
Investing Activities
Capital Expenditure 0 0 0 0
Investments 0 0 0 0
Investing Cash Flow 0 0 0 0
Financing Activities
Debt Repayment 0 16,033 -346,364 -293,971
Common Stock Issued/Repurchased 0 75,000 0 160,000
Dividends Paid 0 0 0 0
Financing Cash Flow 112,858 91,033 346,364 453,971
Summary
Free Cash Flow -141,600 -145,898 -272,209 -450,591
Net Change in Cash -28,834 -54,880 73,915 3,627
Cash Flow Statement (Annual) 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Operating Activities
Net Income -566,293 -142,486 -495,042 -697,379 -910,836
Depreciation & Amortization 0 0 0 1,145 2,434
Stock Based Compensation 0 0 0 0 0
Change in Working Capital 0 116,074 104,308 137,976 220,393
Operating Cash Flow -141,600 -145,898 -272,209 -450,591 -560,432
Investing Activities
Capital Expenditure 0 0 0 0 -1,574
Investments 0 0 0 0 -1,574
Investing Cash Flow 0 0 0 0 -1,574
Financing Activities
Debt Repayment 0 16,033 -346,364 -293,971 0
Common Stock Issued/Repurchased 0 75,000 0 160,000 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow 112,858 91,033 346,364 453,971 535,096
Summary
Free Cash Flow -141,600 -145,898 -272,209 -450,591 -562,006
Net Change in Cash -28,834 -54,880 73,915 3,627 -24,337